chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Injection site pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "Injection site pain".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I have a red rash on my arm surrounding  the injection site.  It is an area of approximately 3 inches by 5 inches. I noticed it on TU morning after my shower. It has increased in size and feels quite itchy.   I have placed a cold compress on it and today I began taking Benedryl.
12 year old received a pediatric dose. Should have received adult dose. Mother ant patient notified.
immed p/vax pt c/o hot face & neck, flat red rash noted on neck & face;VS stable & good no resp distress noted VS monitored, H20 given;
Pt is stp varivax and presented w/mild varicella a few years later. Diagnosis based on clinical exam.
Information has been received from a male physician who "about one week ago" (approximately 03-MAR-2008), was vaccinated with a 0.5 mL subcutaneous dose of varicella virus vaccine live (Oka/Merck) for the prevention of shingles. The physician indicated that he was not sure if it was product confusion, although he state that he had originally ordered the wrong product (varicella virus vaccine live, Oka/Merck), then ordered zoster vaccine live (Oka/Merck). The physician indicated that both vaccines were in the freezer, and "they were not familiar with pediatric vaccines". No adverse experience was related to the event. Current patient status was not reported. A product quality complaint was not reported.
Pregnant patient received 1st dose of Moderna Vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received 1st dose of Moderna Vaccine) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 17-Sep-2020 and the estimated date of delivery was 24-Jun-2021. On 18-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received 1st dose of Moderna Vaccine). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-sixth week of the pregnancy.  On 18-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received 1st dose of Moderna Vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
RIGHT ARM REDNESS, SWELLING, AND HEAT SYMPTOMS NOT STARTING UNTIL 7 DAYS AFTER IMMUNIZATION.  PATIENT ALSO HAS SLIGHT FEVER OF 100.5.  RECOMMENDED THE USE OF TYLENOL, DIPHENHYDRAMINE, AND ICE.  ALSO REFERRED HER TO HER MD TO SEE IF COVID TEST WOULD BE APPROPRIATE.
RASH, REDNESS, ITCHING AND SWOLLEN SIZE OF OF A FIST. CORTIZONE AND ICE APPLIED. BEGAN ON 5/19/2021 STILL EXPERIENCING TWO DAYS LATER. SIGNS OF SWOLLEN GOING DOWN ON 5/21/2021.
The patient was brought to the ED by EMS on 3/13/23 for weakness that began that day. He additionally reported congestion, sore throat, fever, and cough. A COVID PCR test performed in the ED resulted positive. Ultimately, he was admitted 3/13/23 - 3/20/23 with discharge diagnoses of acute hypoxic respiratory failure due to COVID-19 infection and acute on chronic generalized weakness, among other discharge diagnoses. During admission his hypoxia resolved. His acute on chronic generalized weakness was presumably due to COVID-19. Of note, the patient has received the Janssen COVID vaccine and one booster dose.
Moderna COVID-19 Vaccine EUA Fever and body aches started four hours after receiving second dose.  First dose presented with only injection sight soreness for three days.  Currently, as of reporting time, fever is still present going on 18+ hours.  Before using Acetaminophen, temp reached 100.0*F.  With OTC Tylenol, 675mg, temp reduced to 99.2*F.  Currently at time of reporting, no APAP, temp is 99.6*F with aches.
patient developed acute onset of right-sided facial palsy and pain; patient developed acute onset of right-sided facial palsy and pain; Brain MRI done showing T2 hyperintensity in the brainstem and basal ganglia, suspicious for inflammation; This is a spontaneous report from a contactable physician.   A 46-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), on 18Dec2020 at SINGLE DOSE for COVID-19 immunization. Medical history included psoriasis. No COVID prior vaccination. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine.No known allergies. Concomitant medications (received within 2 weeks of vaccination) included fluoxetine. days following vaccination,on 23Dec2020,the patient developed acute onset of right-sided facial palsy and pain. Brain MRI done showing T2 hyperintensity in the brainstem and basal ganglia, suspicious for inflammation. Work-up is ongoing. AE Resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Disability or permanent damage].It was unknown if the event was treated. The event was assessed as serious for Disabling/Incapacitating. The patient had been tested for COVID post vaccination (covid test result-Negative). The outcome of the events werenot recovered    Information about lot/batch number has been requested.; Sender's Comments: A possible causal relationship between acute onset of right-sided facial palsy and pain with MRI findings suspicious for brain inflammation and BNT162B2 cannot be completely ruled out considering the temporal relationship.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Lightheaded and dizziness for nearly 2 weeks now! Symptoms appear when walking. Today, April 24th, nearly two weeks after vaccination, my lightheadedness is the worst it has been and is very troubling. I have not experienced vertigo symptoms ever before this vaccination and have never had issues after other vaccinations before either.
little tired; Initial information received on 20-Mar-2023 regarding an unsolicited valid non-serious case from a consumer/non-hcp.  This case involves a 74-year-old male patient who was little tired after receiving vaccine rabies (HDC) vaccine [Imovax Rabies].  The patient's past medical history included Rabies immunisation in 2011. The patient's past medical treatment(s), vaccination(s), concomitant medication and family history were not provided.   On 17-Mar-2023, the patient received suspect rabies (HDC) vaccine powder and solvent for suspension for injection at a dose of 1 dosage form (DF) once (lot V1D643M, expiry date: 06-Sep-2024) via unknown route in the right arm for bitten by a dog (immunisation).  On an unknown date the patient developed a non-serious little tired (fatigue) (unknown latency) following the administration of rabies (HDC) vaccine.  It was reported consumer says he had the vaccine in 2011 and wants to know if he needs to get the next dose today or can he wait until tomorrow and what happens if he doesn't get it? He has talked with an epidemiologist who said he is low risk but suggest the vaccine which is due to today. He felt a little tired but wants to know if he gets the other symptoms listed in the information provided to him how long would those symptoms last and would they be chronic? When did the vaccine come out? Is the vaccine dangerous?  Action taken: Not applicable.  Corrective treatment: Not reported.  Outcome: Unknown.
I felt a tearing sensation on my left side and went to the doctor,  they did not find anything.  The condition progressed,  I ended up with chronic pain and have never had pain before.  All I do is go to doctors and Physical therapy now.  I was healthy and worked out daily before the vaccine and now I am limited.
Information has been received from a physician and a practice manager via company representative referring to a patient of unknown age and gender. On 04-DEC-2014 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23-10PK- 0.5mlSD-PFS LLokwTip) (lot # K019386, expiration date 09-JUN-2016). This specified lot number vaccine was exposed to temperature excursion once.  The total cumulative excursion time 48 hours with the lowest recorded temperature of 34 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Post Vaccine ten days  fatigue and hypersomnolence still having symptoms as of 4/13/21 (date of office visit). Also reports huge hive two inches from injection site that lasted for ten days.
After the pfizer vaccine, the next day, I was experiencing some pain on my left arm and shoulder.  After 2 days, my pain excerabated and I started vomitting.  I vomitted for over 15 times and my pain went to the sides and lower back.  I went to the doctor  and he checked and said, it was just a side effect of the vaccine and it should disapper in  a day or two.  I was given medication to stop vomitting and some pain medicine.  After I saw the doctor and took the presribed medicine my pain and vomiiting stopped.  I did not go to work for 2 days.
Extreme fatigue for 24 hrs, moderate fatigue for 4 days after. Body aches from head to toe for 24 hrs. Sharp stabbing pain throughout body intermittently for 24 hours. joint pain for 24 hrs. Nausea for 4 hours. Headache for 24 hours.
Delayed onset on fatigue; Delayed onset of severe body aches; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: 2P7534) via an unspecified route of administration in the arm left on 26Mar2021 at 11:30 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. Medical history included ADHD(Attention deficit hyperactivity disorder), de quervain (de quervains thyroiditis), penicillin and sulpha allergy. Concomitant medications included lisdexamfetamine mesilate (VYVANSE) 50 mg daily from unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021, the patient experienced delayed onset on fatigue and severe body aches for more than 10 days. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the reported events. The clinical outcome of the event delayed onset on fatigue and severe body aches was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Not feeling well; fever; This case was reported by a consumer via call center representative and described the occurrence of feeling unwell in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 27th September 2020, the patient received the 1st dose of Shingrix .5 ml. On 2nd October 2020, 5 days after receiving Shingrix, the patient experienced fever. On an unknown date, the patient experienced feeling unwell. On an unknown date, the outcome of the feeling unwell was not recovered/not resolved and the outcome of the fever was unknown.   It was unknown if the reporter considered the feeling unwell and fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The case was reported by patient's wife. Patient's wife reported that her husband (patient) got 1st Shingrix shot and was still not feeling well. Patient developed a fever 5 days after Shingrix injection.  Document from pharmacy says patient received 1 ml but pharmacist said that was incorrect and patient got 0.5ml. The reporter did not consent to follow-up.
Got the shot in his right arm but is experiencing pain in the left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Got the shot in his right arm but is experiencing pain in the left arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Got the shot in his right arm but is experiencing pain in the left arm). At the time of the report, PAIN IN EXTREMITY (Got the shot in his right arm but is experiencing pain in the left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was provided. No treatment medication were provided.   Reporter did not allow further contact
Lost frontal head hair plus mode thinning of balance; Lost frontal head hair plus mode thinning of balance; Remaining hair became very brittle and course; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A male patient received BNT162b2 (BNT162B2), on 07Feb2022 as dose 4 (booster), single (Lot number: FK9729) at the age of 82 years for covid-19 immunisation. The patient's relevant medical history included: "COPD" (unspecified if ongoing), notes: COPD. There were no concomitant medications. Vaccination history included: BNT162b2 (Dose 1:, Time: 10:00 Am, Anatomical site of injection: Arm, Route of administration: Intramuscular, Batch/Lot number: EL3248), administration date: 05Feb2021, for COVID-19 Immunization; BNT162b2 (Dose 2:, Time: 11:00 Am, Anatomical site of injection: Arm, Route of administration: Intramuscular, Batch/Lot number: EL9262), administration date: 26Feb2021, for COVID-19 Immunization; BNT162b2 (Dose 3:, Time: 11:30 Pm, Anatomical site of injection: Arm, Route of administration: Intramuscular, Batch/Lot number: FD8448), administration date: 19Aug2021, for COVID-19 Immunization. The following information was reported: ALOPECIA (non-serious), ALOPECIA (non-serious) all with onset 2022, outcome "unknown" and all described as "Lost frontal head hair plus mode thinning of balance"; TRICHORRHEXIS (non-serious) with onset 2022, outcome "unknown", described as "Remaining hair became very brittle and course". Additional information -It was reported that My wife and I both received a 4th booster shot #FK9729 on 07Feb2022 and within One week we both lost frontal head hair plus mode thinning of balance, also remaining hair became very brittle and course. There were no other negative results No follow-up attempts are needed. No further information is expected.
Joint pain, injection site pain, extreme fatigue, and a 101.4 fever for roughly 12 hours.
This spontaneous report as received from a healthcare worker who was also the patient: a 65 year old female with allergy to penicillin and sulfa drugs. The patient had no pertinent medical history. Her concomitant medication included an unspecified blood pressure, cholesterol and thyroid medication, and metformin. On 09-OCT-2017, the patient was vaccinated with the first dose of PNEUMOVAX 23 (dose, lot number and expiration date were not reported). At that time, the patient experienced no adverse effect. On 24-JUL-2018, the patient was vaccinated with the second dose of PNEUMOVAX 23 lot # N030987, expiry date: 15-MAY-2019, for prophylaxis. On the same date, the patient experienced pain on injection site, headache and pain in the back of the neck. The patient sought medical attention by calling the physician. She received unspecified treatment for the events. The outcome of the events was reported as not recovered. The causality assessment was not provided.
Nausea, vomiting, burning in stomach, high blood sugars- symptoms started the day after the vaccine. Found obtunded 3 days after vaccine given. 911 called in route to the hospital had a cardiac arrest, resuscitated, arrested again and resuscitated. Upon admission to the hospital diagnosed with diabetic ketoacidosis and died the next day- 4 days after the vaccine was administered
first 2 days, normal side effects (sore arm, fatigue) then day 3 dizziness and nausea all day and still  happening after 15 days. has not gone away yet
I had hives since getting the first dose that hadn't gone away.  After getting my second dose, I still had the hives and I woke up in the middle of the night and they had spread; I had them on my upper legs, my butt, my stomach, my back, my arms....  I went back to bed and managed to fall asleep.  I was then woken up by my husband who informed me that my eyes were a little swollen and my lips were quite swollen.  I had been told when I got my second dose to go to the ER if I had any swelling on my face, so my husband drove me to the ER.  They admitted me and gave me Prednisone, Pepcid and Benadryl intravenously; I was at the ER for about five hours before I was sent home with a nine day prescription for Prednisone and a prescription for an Epi-Pen; the doctor also told me to take one or two Benadryl every six hours for 24 hours.  Two days later I had an appointment with an allergist who told me to start taking two Allegra in the morning and two Zyrtec in the evening.  She also prescribed me Doxepin to help me sleep (I hadn't been sleeping well because the itching was keeping me awake).  Two days after that I had a follow-up appointment with my GP.  She was on board with everything the allergist said.
HEADACHE; FEVER; This spontaneous report received from a patient concerned a 48 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802072, and batch number: 1802072 expiry: UNKNOWN) dose was not reported, administered on 24-MAR-2021 for prophylactic vaccination. Vaccinated at left arm. No concomitant medications were reported. On 24-MAR-2021, the subject experienced headache. On 24-MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on 25-MAR-2021, and had not recovered from headache. This report was non-serious.
Patient was admitted with 3 seperate episodes of Right sided hemiparesis and right sided facial droop concerning for TIA vs Stroke vs Seizure like episode
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding concomitant medications concurrent conditions or medical history. In 2015, the patient was inoculated with ZOSTAVAX by a healthcare provider to obtain permanent prevention and protection against shingles and zoster-related injuries (dose, route, and lot # not provided). In 2016, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient had and would continue suffered ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was unknown. Causality assessment was related.
Within minutes, pt had hives over entire body, was coughing, wheezing, threw up, lip swelling. Gave Epi 0.2 mL of 1:1000 IM, BENADRYL 5mL PO, DECADRON 10mg IM, XOPENEX 1.25 INH. Sent home on BENADRYL q 4 hours, Ranitidine q 12 x 2 doses. Sx's quickly resolved (within 5-10 minutes).
Because it was a requirement of the facility, my son received his third Pfizer shot (booster) and seven days later was diagnosed with Epididymitis.  He tested negative for any STI or STD's.
Within 15 minutes of receiving vaccine patient had complaints of back of head pain 9/10. Patient had some blurring of vision. EMS was called, patient refused care and stated he would go to Store to get Excedrin for his headache and drive home if able. Nurse and EMS personnel informed the patient to not drive if his blurred vision did not improve. Patient stated he would call a ride if he needed to. Patient was concerned of paying for any care as he does not have insurance.
Achiness; Tested positive for COVID-19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Tested positive for COVID-19) and PAIN (Achiness) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939903, 010A21A and 032L20A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In 2022, the patient experienced COVID-19 (Tested positive for COVID-19). On an unknown date, the patient experienced PAIN (Achiness). The patient was treated with ACETYLSALICYLIC ACID, CAFFEINE (ANACIN [ACETYLSALICYLIC ACID;CAFFEINE]) for Ache, at an unspecified dose and frequency. At the time of the report, COVID-19 (Tested positive for COVID-19) and PAIN (Achiness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2022, SARS-CoV-2 test: Positive.         No concomitant medications were reported.  It was reported that around approximately 30-May-2022, patient thought she had a cold, took a COVID test, and tested positive for COVID-19. Patient might had taken Anacin for achiness but did not remember.
This spontaneous report as received from a patient's mother refers to a female patient who at the age of 15 years old in approximately 2010 was vaccinated with GARDASIL dose 1, (dose and application site unspecified) (lot and exp date unspecified). The reporter stated that at the reporting time the patient was eighteen years of age, but has only received one dose of the vaccine, and dose prescribing information. No adverse effect was reported. The patient's outcome was unknown. Additional information is not expected.